In a story Nov. 5 about the drug Cymbalta’s latest approval for musculoskeletal pain, The Associated Press erroneously reported that Cymbalta was already approved as a treatment for chronic low back pain
Excerpt from:
Correction: Eli Lilly-Cymbalta – msnbc.com
